BioInteractions
- Company typePrivate
- Founded1992
- HeadquartersShinfield, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
BioInteractions firmographics
Firmographics- Name
- BioInteractions
- Legal name
- BioInteractions Ltd
- Website
- https://biointeractions.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
BioInteractions industry classification
Industry- Product category
- Medical Device Coatings
- NAICS
- Paint and Coating Manufacturing (32551), Paint and Coating Manufacturing (325510)
- SIC
- Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating) (IMAIAKAM)
- akta.pro secondary industry
- Industrial & Protective Coatings (IMAEAGAB)
Keywords
Where BioInteractions is headquartered
LocationHeadquarters
- HQ city
- Shinfield
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
BioInteractions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Licensing Contracts: BioInteractions has secured licensing contracts with major medical device manufacturers worldwide for the use of their coating technologies on approved devices.
- Product Pathway Partnership Service: Integrated end-to-end coating service supporting partners from concept to commercialisation, including application development, tooling, testing, regulatory submission, and scaled assembly.
- Bespoke Materials: Custom-made coating solutions for partners requiring surface treatments outside standard offerings, leveraging 30+ years of biocompatible material expertise.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
BioInteractions product offering
Product offeringCore offering
BioInteractions develops and supplies proprietary zero-leaching biocompatible coatings for medical devices under its Surface-Active Systems platform. Its core commercial products are AstutePlus (antithrombogenic coating for blood-contacting devices), TridAnt (permanent antimicrobial coating), and Assist (durable hydrophilic friction-reduction coating), complemented by bespoke custom coating development and an end-to-end Product Pathway Partnership service for OEMs.
Product overview
BioInteractions offers a portfolio of biocompatible coating solutions organized under the Surface-Active Systems platform. The core product line includes three main coatings: AstutePlus® (advanced antithrombogenic for blood-contacting devices), TridAnt® (enhanced antimicrobial for infection prevention), and Assist™ (durable hydrophilic for friction reduction). These are complemented by Surface-Active Systems, a new category combining Surface-Active Therapeutics and Surface-Active Materials. The company also provides Bespoke Materials services for custom coating solutions and a Product Pathway Partnership service for end-to-end development support.
Differentiator
Problem solved
Functional benefit
Brands
- AstutePlus®: Advanced antithrombogenic Surface-Active Therapeutic coating designed for long-term blood-contacting medical devices, providing zero-leaching, permanently effective thrombosis prevention
- TridAnt®
- Assist™
- Surface-Active Systems
- Surface-Active Therapeutics
- Surface-Active Materials
Products and services
- AstutePlus Advanced Antithrombogenic Coating Zero-leaching, permanently effective antithrombogenic Surface-Active Therapeutic coating for long-term blood-contacting medical devices. Multi-faceted action blocks the blood cascade, deactivates platelets, and prevents blood components from sticking. Prevents 99% of thrombosis and fibrin sheath formation, and mimics endothelial tissue. Targeted at medical device OEMs producing stents, valves, catheters, vascular grafts, and oxygenators.
- TridAnt Enhanced Antimicrobial Coating Zero-leaching permanent antimicrobial Surface-Active Therapeutic coating effective against gram-negative (E. coli), gram-positive bacteria (including MRSA), yeast, and fungi. Uses a Contact Kill Mechanism to inhibit protein deposition and bacterial adhesion while killing pathogens. Designed for medical device OEMs requiring infection-prevention coatings on implantable and indwelling devices.
- Assist Durable Hydrophilic Coating Durable hydrophilic Surface-Active Material engineered to reduce friction on medical device surfaces, suitable for high-stress applications including balloon catheters and joint devices. Features industry-leading coefficient of friction (<0.003), instant activation, minimal swelling (2%), and ultra-low particulation. UV or heat cured. Targeted at medical device OEMs needing lubricious, durable surface treatments.
- Bespoke Materials Custom-made coating solutions for OEM partners requiring surface treatments outside standard clinical areas. Leverages 30+ years of biocompatible material expertise, including biocompatible polymers, biodegradable materials, drug delivery systems, and biomedical technologies, developed on-site at the company's production laboratory in Shinfield, UK.
- Product Pathway Partnership Integrated end-to-end coating service supporting OEM partners from concept to commercialisation. Includes application development, tooling, testing, regulatory submission, and scaled assembly services, with regulatory compliance at its core. Designed for medical device manufacturers seeking a single partner across the device coating lifecycle.
Quantifiable outcome
- Prevents 99% of thrombosis formation
- +3 more outcomes
Companies that use BioInteractions
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
BioInteractions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioInteractions partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Major Medical Device Manufacturers WorldwidecoreBioInteractions works with major manufacturers worldwide in the areas of cardiothoracic surgery, drug delivery, catheters, and long-term implantable medical devices such as vascular grafts. The company has secured licensing contracts with these manufacturers for their coating technologies.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
BioInteractions competitors and assessment
Company assessmentDirect peers
- Innovative Surface Technologies: Innovative Surface Technologies (ISurTec) develops specialized surface coatings including hydrophilic, antimicrobial, and drug-eluting coatings for medical devices. Direct peer in the niche biocompatible coating space serving similar OEM applications.
- Covalon Technologies: Covalon Technologies develops antimicrobial and biocompatible coatings for medical devices, with overlap in infection-prevention coatings similar to BioInteractions' TridAnt. Both target the healthcare-associated infection reduction use case for medical device OEMs.
- Biocoat: Biocoat specializes in hydrophilic coatings for medical devices, directly comparable to BioInteractions' Assist product. Serves similar OEM customers in catheters and minimally invasive devices with focused surface coating technology.
- Surmodics: Surmodics is a direct competitor providing specialized surface coatings for medical devices, including hydrophilic, antithrombogenic, and drug-delivery coatings. It serves the same medical device OEM customer base across interventional and implantable devices, making it the most comparable public peer in biocompatible medical device coatings.
- Harland Medical Systems: Harland Medical Systems provides medical device surface coatings and surface treatment technologies, including lubricious and antimicrobial coatings. Directly comparable niche competitor serving medical device OEMs with similar coating services.
Emerging players
- AST Products: AST Products develops surface modification technologies including lubricious and antimicrobial coatings for medical and industrial applications. Comparable niche competitor in functional surface treatments, though smaller scale and broader end-market exposure.
- N8 Medical: N8 Medical develops antimicrobial coating technologies for medical devices, focused on infection prevention. Comparable to BioInteractions' TridAnt in addressing HCAI risk through surface-bound antimicrobial approaches, though at earlier commercial scale.
- AdvaTec: AdvaTec develops antimicrobial and anti-thrombogenic coatings for medical devices, with overlap in biocompatible infection-prevention surfaces. Smaller competitor focused on similar cardiovascular and catheter device applications.
Broad incumbents
- Teleflex: Teleflex is a major medical device OEM whose coated catheter and vascular access products (e.g., Certofix) are named customers/partners of BioInteractions. As a downstream OEM rather than a coating technology peer, it is a meaningful adjacent player whose commercial decisions directly affect BioInteractions' licensing revenue.
- DSM Biomedical: DSM Biomedical (formerly DSM Dyneema and Polymer Technology Group) is a larger incumbent supplying biocompatible materials and coatings for medical devices, including drug-delivery and regenerative coatings. Overlaps directly with BioInteractions in antithrombogenic and biocompatible surface technologies but operates at substantially larger scale and broader product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
BioInteractions social profiles
Digital presenceBioInteractions compliance and trust
Trust signalCompliance3 records
BioInteractions financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioInteractions leadership team
Management profileNumber of profiles
Profiles2 records
BioInteractions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioInteractions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioInteractions
What does BioInteractions do?
BioInteractions develops and supplies proprietary zero-leaching biocompatible coatings for medical devices under its Surface-Active Systems platform. Its core commercial products are AstutePlus (antithrombogenic coating for blood-contacting devices), TridAnt (permanent antimicrobial coating), and Assist (durable hydrophilic friction-reduction coating), complemented by bespoke custom coating development and an end-to-end Product Pathway Partnership service for OEMs.
Is BioInteractions a public or private company?
BioInteractions is a private company. It is classified as family owned and is currently operating.
When was BioInteractions founded?
BioInteractions was founded in 1992. It employs 11 to 50 people.
Where is BioInteractions based?
BioInteractions is headquartered in Shinfield, United Kingdom, in the Europe region.
How does BioInteractions make money?
Three revenue lines are on record. Licensing Contracts are the primary driver. The others are product Pathway Partnership Service and bespoke Materials.
Who are BioInteractions's main competitors?
Direct peers on record are Innovative Surface Technologies, Covalon Technologies, Biocoat, Surmodics and Harland Medical Systems. Emerging players are AST Products, N8 Medical and AdvaTec. Broad incumbents are Teleflex and DSM Biomedical.
Does BioInteractions have an API?
No public API is recorded for BioInteractions.
What industry is BioInteractions in?
BioInteractions's product category is Medical Device Coatings. Its primary akta.pro industry code is IMAIAKAM, Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating), with a secondary code of IMAEAGAB, Industrial & Protective Coatings. Its NAICS code is 32551 and its SIC code is 2851.